Triethylene Glycol

Triethylene Glycol

SCHEMBL379325

Cc1cc(C(C)C(=O)O)cc(C(C)(C)C)c1O.Cc1cc(C(C)C(=O)O)cc(C(C)(C)C)c1O.OCCOCCOCCO

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
AKR1C3 P42330 9/20 0.36
AKR1C2 P52895 9/20 0.36
GLRA3 O75311 1/20 0.35
GLRB P48167 1/20 0.35
GPR55 Q9Y2T6 1/20 0.34
CYP2D6 P10635 1/20 0.34
VCAM1 P19320 3/20 0.33
HMGCR P04035 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CA2 P00918 1/20 0.32
POLB P06746 1/20 0.32
TYR P14679 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CACNA1A O00555 1/20 0.31
CACNA2D1 P54289 1/20 0.31
CACNB1 Q02641 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triethylene Glycol SCHEMBL10455917 1.00 CYP1A2 (0.39) CYP1A2CYP2C9CYP2C19AKR1C3AKR1C2
SCHEMBL7108121 0.87 CYP1A2 (0.50) CYP1A2CYP2C9CYP2C19AKR1C3AKR1C2
SCHEMBL29408356 0.87 CYP1A2 (0.50) CYP1A2CYP2C9CYP2C19AKR1C3AKR1C2
SCHEMBL283603 0.87 CYP1A2 (0.50) CYP1A2CYP2C9CYP2C19AKR1C3AKR1C2
Triethylene Glycol SCHEMBL1434840 0.86 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19AKR1C3AKR1C2
SCHEMBL38652043 0.85 CYP1A2 (0.49) CYP1A2CYP2C9CYP2C19AKR1C3AKR1C2
SCHEMBL379324 0.83 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19GLRA3GLRB
SCHEMBL29405981 0.83 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19GLRA3GLRB
SCHEMBL29349883 0.83 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19GLRA3GLRB
SCHEMBL2354392 0.82 CYP1A2 (0.36) CYP1A2CYP2C9CYP2C19GLRA3GLRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 378 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024090855-A1 ISOCYANATE COMPOSITION 한화솔루션 주식회사 2024-05-02 WO claimed
WO-2024049033-A1 ISOCYANATE COMPOSITION 한화솔루션 주식회사 2024-03-07 WO claimed
US-9133121-B2 Weakly basic hindered amines compounds having carbonate skeletons, synthetic resin compositions and coating compositions NEGISHI YOSHINORI (JP) 2015-09-15 US claimed
JP-3068656-A None JP disclosed
EP-4726011-A1 FLAME RETARDANT, COMPOSITION, AND MOLDED ARTICLE ADEKA CORPORATION (JP) 2026-04-15 EP disclosed
US-20260092163-A1 FLAME-RETARDANT COMPOSITION, FLAME-RETARDANT RESIN COMPOSITION, AND MOLDED PRODUCT ADEKA CORPORATION (JP) 2026-04-02 US disclosed
EP-4678699-A1 RESIN ADDITIVE, COMPOSITION, MOLDED ARTICLE AND COMPOUND ADEKA CORPORATION (JP) 2026-01-14 EP disclosed
WO-2025215193-A1 ACIDIC OLIGOMERS USED IN DEINKING PROCESS ARKEMA FRANCE (FR) 2025-10-16 WO disclosed
EP-4632041-A1 FLAME-RETARDANT COMPOSITION, FLAME-RETARDANT RESIN COMPOSITION AND MOLDED ARTICLE ADEKA CORPORATION (JP) 2025-10-15 EP disclosed
EP-4606866-A1 RESIN COMPOSITION, METHOD FOR PRODUCING RESIN PRODUCT, AND FLAME RETARDANT MASTERBATCH Mitsubishi Chemical Corporation (JP) 2025-08-27 EP disclosed
US-20250243329-A1 RESIN COMPOSITION, METHOD FOR PRODUCING RESIN PRODUCT, AND FLAME RETARDANT MASTERBATCH MITSUBISHI CHEMICAL CORPORATION (JP) 2025-07-31 US disclosed
EP-0761756-B1 STABILIZER FOR HALOGEN-CONTAINING RESINS AND PROCESS FOR THE PREPARATION THEREOF, HALOGEN-CONTAINING RESIN COMPOSITION, AND COMPOSITE HYDROXIDE SALT FUJI CHEM IND CO LTD (JP) 1999-10-27 EP disclosed
EP-0672619-B1 Lithium aluminium complex hydroxide salt, blending agent for resin and resin composition MIZUSAWA INDUSTRIAL CHEM (JP) 1999-06-02 EP disclosed
EP-0778241-B1 NOVEL COMPOSITE HYDROXIDE/CONDENSED SILICATES, PROCESS FOR THE PRODUCTION THEREOF, INFRARED ABSORBER, AND AGRICULTURAL FILM FUJI CHEM IND CO LTD (JP) 1999-05-12 EP disclosed
EP-0874012-A1 Coating composition for optical fiber TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-10-28 EP disclosed
EP-0849296-A2 A photocurable resin composition and a method for producing the same TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-06-24 EP disclosed
EP-0790214-A1 COMPOSITE ALKALI ALUMINUM HYDROXIDE CARBONATE, AND PROCESS FOR PRODUCTION AND USE THEREOF MIZUSAWA INDUSTRIAL CHEMICALS, LTD. (JP) 1997-08-20 EP disclosed
EP-0778241-A1 NOVEL COMPOSITE HYDROXIDE/CONDENSED SILICATES, PROCESS FOR THE PRODUCTION THEREOF, INFRARED ABSORBER, AND AGRICULTURAL FILM FUJI CHEMICAL INDUSTRY CO., LTD. (JP) 1997-06-11 EP disclosed
EP-0672619-A1 Lithium aluminium complex hydroxide salt, blending agent for resin and resin composition MIZUSAWA INDUSTRIAL CHEMICALS, LTD. (JP) 1995-09-20 EP disclosed
JP-H0368656-A POLYPHENYLENE SULFIDE COMPOSITION TORAY IND INC 1991-03-25 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260092163-A1 FLAME-RETARDANT COMPOSITION, FLAME-RETARDANT RESIN COMPOSITION, AND MOLDED PRODUCT PHOSPHO1, PAF1, PPA1 CYP1A2 4225/4885CYP2C9 4704/4885CYP2C19 4702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.